Open AccessEfficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients
Author(s) -
Xiaowei Cheng,
Wen-Hua Leng,
Chun-Ling Mu
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i21.5172
Subject(s) - medicine , gemcitabine , nausea , lung cancer , incidence (geometry) , vomiting , quality of life (healthcare) , diarrhea , oncology , chemotherapy , gastroenterology , physics , nursing , optics
Previous reports have demonstrated that S-1 has remarkable effects in the maintenance treatment of advanced non-small-cell lung cancer (NSCLC), and has less toxic and side effects than conventional drugs.